nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—kidney cancer	0.601	1	CiPCiCtD
Capecitabine—CDA—Gemcitabine—kidney cancer	0.16	0.664	CbGbCtD
Capecitabine—TYMS—Gemcitabine—kidney cancer	0.0711	0.296	CbGbCtD
Capecitabine—CYP2C9—Paclitaxel—kidney cancer	0.00508	0.0211	CbGbCtD
Capecitabine—CYP2C9—Sorafenib—kidney cancer	0.00451	0.0188	CbGbCtD
Capecitabine—DPYD—nephron tubule—kidney cancer	0.000936	0.173	CbGeAlD
Capecitabine—DPYD—cortex of kidney—kidney cancer	0.000801	0.148	CbGeAlD
Capecitabine—DPYD—cardiac atrium—kidney cancer	0.000762	0.141	CbGeAlD
Capecitabine—CYP2C9—urine—kidney cancer	0.000754	0.14	CbGeAlD
Capecitabine—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.000477	0.27	CbGdCrCtD
Capecitabine—TYMS—nephron tubule—kidney cancer	0.000465	0.0861	CbGeAlD
Capecitabine—TYMP—cortex of kidney—kidney cancer	0.000464	0.0859	CbGeAlD
Capecitabine—TYMP—cardiac atrium—kidney cancer	0.000441	0.0817	CbGeAlD
Capecitabine—TYMS—cortex of kidney—kidney cancer	0.000398	0.0737	CbGeAlD
Capecitabine—TYMS—gonad—kidney cancer	0.000379	0.0702	CbGeAlD
Capecitabine—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000229	0.13	CbGdCrCtD
Capecitabine—TYMS—Sirolimus—Everolimus—kidney cancer	0.000229	0.13	CbGdCrCtD
Capecitabine—TYMS—Gefitinib—Erlotinib—kidney cancer	0.000228	0.129	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000153	0.0866	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000153	0.0866	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinblastine—kidney cancer	0.000131	0.074	CbGdCrCtD
Capecitabine—TYMS—Vinblastine—Vincristine—kidney cancer	0.000105	0.0595	CbGdCrCtD
Capecitabine—CDA—Metabolism—FH—kidney cancer	7.21e-05	0.00237	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALAD—kidney cancer	7.21e-05	0.00237	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CCBL1—kidney cancer	7.15e-05	0.00235	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ST3GAL2—kidney cancer	7.04e-05	0.00231	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	7.02e-05	0.00231	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—kidney cancer	6.9e-05	0.00227	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALDH1A1—kidney cancer	6.88e-05	0.00226	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GPC3—kidney cancer	6.78e-05	0.00223	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA2—kidney cancer	6.6e-05	0.00217	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC5A3—kidney cancer	6.6e-05	0.00217	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PGK1—kidney cancer	6.6e-05	0.00217	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—kidney cancer	6.57e-05	0.00216	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.54e-05	0.00215	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.54e-05	0.00215	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—LDHB—kidney cancer	6.47e-05	0.00213	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALAD—kidney cancer	6.43e-05	0.00211	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—kidney cancer	6.41e-05	0.00211	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ST3GAL2—kidney cancer	6.27e-05	0.00206	CbGpPWpGaD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	6.26e-05	0.00206	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	6.25e-05	0.00206	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPAT—kidney cancer	6.2e-05	0.00204	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GLIPR1—kidney cancer	6.2e-05	0.00204	CbGpPWpGaD
Capecitabine—TYMS—Azacitidine—Gemcitabine—kidney cancer	6.16e-05	0.0349	CbGdCrCtD
Capecitabine—CDA—Metabolism—ALDH1A1—kidney cancer	6.13e-05	0.00202	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.11e-05	0.00201	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	5.96e-05	0.00196	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PGK1—kidney cancer	5.88e-05	0.00193	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC5A3—kidney cancer	5.88e-05	0.00193	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—EGR1—kidney cancer	5.87e-05	0.00193	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN1B—kidney cancer	5.82e-05	0.00191	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LDHB—kidney cancer	5.76e-05	0.0019	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—FH—kidney cancer	5.76e-05	0.0019	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APRT—kidney cancer	5.76e-05	0.0019	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA9—kidney cancer	5.61e-05	0.00184	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	5.52e-05	0.00181	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPC3—kidney cancer	5.42e-05	0.00178	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.37e-05	0.00177	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.32e-05	0.00175	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA2—kidney cancer	5.27e-05	0.00173	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.2e-05	0.00171	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALAD—kidney cancer	5.14e-05	0.00169	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	5.05e-05	0.00166	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ST3GAL2—kidney cancer	5.01e-05	0.00165	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA9—kidney cancer	5e-05	0.00164	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALDH1A1—kidney cancer	4.9e-05	0.00161	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	4.82e-05	0.00159	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CRABP1—kidney cancer	4.77e-05	0.00157	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PGK1—kidney cancer	4.7e-05	0.00155	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC5A3—kidney cancer	4.7e-05	0.00155	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LDHB—kidney cancer	4.61e-05	0.00152	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ACY1—kidney cancer	4.58e-05	0.00151	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—kidney cancer	4.45e-05	0.00146	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ITPR2—kidney cancer	4.43e-05	0.00146	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.38e-05	0.00144	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CRABP1—kidney cancer	4.25e-05	0.0014	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	4.23e-05	0.00139	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CDKN1B—kidney cancer	4.22e-05	0.00139	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTT1—kidney cancer	4.04e-05	0.00133	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ACHE—kidney cancer	4.04e-05	0.00133	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	4.03e-05	0.00133	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	4.02e-05	0.00132	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA9—kidney cancer	4e-05	0.00131	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ITPR2—kidney cancer	3.95e-05	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PDHB—kidney cancer	3.89e-05	0.00128	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	3.87e-05	0.00127	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SCARB1—kidney cancer	3.83e-05	0.00126	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS1—kidney cancer	3.79e-05	0.00125	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.75e-05	0.00123	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PSMD7—kidney cancer	3.71e-05	0.00122	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CCBL1—kidney cancer	3.66e-05	0.0012	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTT1—kidney cancer	3.6e-05	0.00118	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ACHE—kidney cancer	3.6e-05	0.00118	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	3.56e-05	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PSMD7—kidney cancer	3.52e-05	0.00116	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BCHE—kidney cancer	3.52e-05	0.00116	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.48e-05	0.00115	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC5A5—kidney cancer	3.48e-05	0.00114	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.44e-05	0.00113	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—AURKA—kidney cancer	3.43e-05	0.00113	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SCARB1—kidney cancer	3.41e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CRABP1—kidney cancer	3.4e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—kidney cancer	3.39e-05	0.00112	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS1—kidney cancer	3.38e-05	0.00111	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC2A1—kidney cancer	3.36e-05	0.0011	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PSMD7—kidney cancer	3.31e-05	0.00109	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—kidney cancer	3.23e-05	0.00106	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.18e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GLIPR1—kidney cancer	3.17e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPAT—kidney cancer	3.17e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ITPR2—kidney cancer	3.16e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PSMD7—kidney cancer	3.15e-05	0.00104	CbGpPWpGaD
Capecitabine—CDA—Metabolism—BCHE—kidney cancer	3.14e-05	0.00103	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC5A5—kidney cancer	3.1e-05	0.00102	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—AURKA—kidney cancer	3.07e-05	0.00101	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC2A1—kidney cancer	2.99e-05	0.000985	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APRT—kidney cancer	2.95e-05	0.00097	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FH—kidney cancer	2.95e-05	0.00097	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.94e-05	0.000967	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.91e-05	0.000957	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ACHE—kidney cancer	2.88e-05	0.000947	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTT1—kidney cancer	2.88e-05	0.000947	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.85e-05	0.000936	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.82e-05	0.000928	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTP1—kidney cancer	2.8e-05	0.000921	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPC3—kidney cancer	2.77e-05	0.000912	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SCARB1—kidney cancer	2.73e-05	0.000897	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—kidney cancer	2.72e-05	0.000895	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS1—kidney cancer	2.7e-05	0.000888	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CA2—kidney cancer	2.7e-05	0.000887	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.69e-05	0.000886	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCB1—kidney cancer	2.65e-05	0.000872	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PSMD7—kidney cancer	2.65e-05	0.000871	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALAD—kidney cancer	2.63e-05	0.000864	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.6e-05	0.000854	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.58e-05	0.000847	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—kidney cancer	2.57e-05	0.000847	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.57e-05	0.000845	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ST3GAL2—kidney cancer	2.57e-05	0.000844	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.57e-05	0.000844	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.55e-05	0.000837	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BCHE—kidney cancer	2.51e-05	0.000825	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALDH1A1—kidney cancer	2.51e-05	0.000825	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTP1—kidney cancer	2.5e-05	0.000821	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—kidney cancer	2.48e-05	0.000817	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.48e-05	0.000816	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC5A5—kidney cancer	2.48e-05	0.000815	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—JUN—kidney cancer	2.46e-05	0.00081	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1A1—kidney cancer	2.44e-05	0.000803	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PGK1—kidney cancer	2.4e-05	0.000791	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC5A3—kidney cancer	2.4e-05	0.000791	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	2.4e-05	0.000788	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A1—kidney cancer	2.39e-05	0.000787	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—kidney cancer	2.38e-05	0.000783	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—kidney cancer	2.36e-05	0.000777	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LDHB—kidney cancer	2.36e-05	0.000775	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—PTGS1—kidney cancer	2.33e-05	0.000765	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BRCA2—kidney cancer	2.32e-05	0.000764	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2B—kidney cancer	2.3e-05	0.000757	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTM1—kidney cancer	2.29e-05	0.000755	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.24e-05	0.000737	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	2.22e-05	0.000731	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1A1—kidney cancer	2.18e-05	0.000716	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.12e-05	0.000697	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.1e-05	0.000692	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.06e-05	0.000678	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.05e-05	0.000675	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CA9—kidney cancer	2.04e-05	0.000672	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.02e-05	0.000663	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTP1—kidney cancer	2e-05	0.000657	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BIRC5—kidney cancer	1.99e-05	0.000654	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.91e-05	0.000627	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCB1—kidney cancer	1.89e-05	0.000622	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—kidney cancer	1.83e-05	0.000603	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—POMC—kidney cancer	1.82e-05	0.000599	CbGpPWpGaD
Capecitabine—Hypersensitivity—Sunitinib—kidney cancer	1.79e-05	0.000148	CcSEcCtD
Capecitabine—Decreased appetite—Vincristine—kidney cancer	1.79e-05	0.000147	CcSEcCtD
Capecitabine—Pruritus—Sorafenib—kidney cancer	1.79e-05	0.000147	CcSEcCtD
Capecitabine—Vomiting—Erlotinib—kidney cancer	1.79e-05	0.000147	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	1.78e-05	0.000147	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Vincristine—kidney cancer	1.78e-05	0.000146	CcSEcCtD
Capecitabine—Fatigue—Vincristine—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Rash—Erlotinib—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Dermatitis—Erlotinib—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Palpitations—Paclitaxel—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Hyponatraemia—Doxorubicin—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Insomnia—Gemcitabine—kidney cancer	1.77e-05	0.000146	CcSEcCtD
Capecitabine—Headache—Erlotinib—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Loss of consciousness—Paclitaxel—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Constipation—Vincristine—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Pain—Vincristine—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Osteoarthritis—Doxorubicin—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Pain in extremity—Doxorubicin—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Diplopia—Doxorubicin—kidney cancer	1.76e-05	0.000145	CcSEcCtD
Capecitabine—Paraesthesia—Gemcitabine—kidney cancer	1.75e-05	0.000145	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.75e-05	0.000576	CbGpPWpGaD
Capecitabine—Cough—Paclitaxel—kidney cancer	1.75e-05	0.000144	CcSEcCtD
Capecitabine—Asthenia—Sunitinib—kidney cancer	1.75e-05	0.000144	CcSEcCtD
Capecitabine—Dyspnoea—Gemcitabine—kidney cancer	1.74e-05	0.000143	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYP1A1—kidney cancer	1.74e-05	0.000572	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CRABP1—kidney cancer	1.74e-05	0.000572	CbGpPWpGaD
Capecitabine—Nausea—Vinblastine—kidney cancer	1.74e-05	0.000143	CcSEcCtD
Capecitabine—Migraine—Doxorubicin—kidney cancer	1.73e-05	0.000143	CcSEcCtD
Capecitabine—Nausea—Everolimus—kidney cancer	1.73e-05	0.000143	CcSEcCtD
Capecitabine—Diarrhoea—Sorafenib—kidney cancer	1.73e-05	0.000143	CcSEcCtD
Capecitabine—Hypertension—Paclitaxel—kidney cancer	1.73e-05	0.000143	CcSEcCtD
Capecitabine—Pruritus—Sunitinib—kidney cancer	1.72e-05	0.000142	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	1.72e-05	0.000566	CbGpPWpGaD
Capecitabine—Chest pain—Paclitaxel—kidney cancer	1.71e-05	0.000141	CcSEcCtD
Capecitabine—Arthralgia—Paclitaxel—kidney cancer	1.71e-05	0.000141	CcSEcCtD
Capecitabine—Myalgia—Paclitaxel—kidney cancer	1.71e-05	0.000141	CcSEcCtD
Capecitabine—Anxiety—Paclitaxel—kidney cancer	1.7e-05	0.00014	CcSEcCtD
Capecitabine—Face oedema—Doxorubicin—kidney cancer	1.7e-05	0.00014	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	1.7e-05	0.000558	CbGpPWpGaD
Capecitabine—Decreased appetite—Gemcitabine—kidney cancer	1.7e-05	0.00014	CcSEcCtD
Capecitabine—Hypersensitivity—Dactinomycin—kidney cancer	1.7e-05	0.00014	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	1.69e-05	0.00014	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.69e-05	0.000557	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.69e-05	0.000139	CcSEcCtD
Capecitabine—Discomfort—Paclitaxel—kidney cancer	1.69e-05	0.000139	CcSEcCtD
Capecitabine—Fatigue—Gemcitabine—kidney cancer	1.68e-05	0.000139	CcSEcCtD
Capecitabine—Gastrointestinal pain—Vincristine—kidney cancer	1.68e-05	0.000139	CcSEcCtD
Capecitabine—Cardiac arrest—Doxorubicin—kidney cancer	1.67e-05	0.000138	CcSEcCtD
Capecitabine—Dizziness—Sorafenib—kidney cancer	1.67e-05	0.000138	CcSEcCtD
Capecitabine—Pain—Gemcitabine—kidney cancer	1.67e-05	0.000138	CcSEcCtD
Capecitabine—Constipation—Gemcitabine—kidney cancer	1.67e-05	0.000138	CcSEcCtD
Capecitabine—Nausea—Erlotinib—kidney cancer	1.67e-05	0.000138	CcSEcCtD
Capecitabine—Dry mouth—Paclitaxel—kidney cancer	1.67e-05	0.000137	CcSEcCtD
Capecitabine—Mood swings—Doxorubicin—kidney cancer	1.67e-05	0.000137	CcSEcCtD
Capecitabine—Diarrhoea—Sunitinib—kidney cancer	1.67e-05	0.000137	CcSEcCtD
Capecitabine—Ataxia—Doxorubicin—kidney cancer	1.65e-05	0.000136	CcSEcCtD
Capecitabine—Asthenia—Dactinomycin—kidney cancer	1.65e-05	0.000136	CcSEcCtD
Capecitabine—Confusional state—Paclitaxel—kidney cancer	1.65e-05	0.000136	CcSEcCtD
Capecitabine—Blood creatinine increased—Doxorubicin—kidney cancer	1.65e-05	0.000136	CcSEcCtD
Capecitabine—Dehydration—Doxorubicin—kidney cancer	1.64e-05	0.000135	CcSEcCtD
Capecitabine—Oedema—Paclitaxel—kidney cancer	1.64e-05	0.000135	CcSEcCtD
Capecitabine—Body temperature increased—Vincristine—kidney cancer	1.63e-05	0.000134	CcSEcCtD
Capecitabine—Abdominal pain—Vincristine—kidney cancer	1.63e-05	0.000134	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—kidney cancer	1.63e-05	0.000535	CbGpPWpGaD
Capecitabine—Liver function test abnormal—Doxorubicin—kidney cancer	1.62e-05	0.000134	CcSEcCtD
Capecitabine—Infection—Paclitaxel—kidney cancer	1.62e-05	0.000134	CcSEcCtD
Capecitabine—CDA—Metabolism—POMC—kidney cancer	1.62e-05	0.000533	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ITPR2—kidney cancer	1.62e-05	0.000531	CbGpPWpGaD
Capecitabine—Dry skin—Doxorubicin—kidney cancer	1.61e-05	0.000133	CcSEcCtD
Capecitabine—Dizziness—Sunitinib—kidney cancer	1.61e-05	0.000133	CcSEcCtD
Capecitabine—Feeling abnormal—Gemcitabine—kidney cancer	1.61e-05	0.000133	CcSEcCtD
Capecitabine—Shock—Paclitaxel—kidney cancer	1.61e-05	0.000133	CcSEcCtD
Capecitabine—Vomiting—Sorafenib—kidney cancer	1.61e-05	0.000133	CcSEcCtD
Capecitabine—Orthostatic hypotension—Doxorubicin—kidney cancer	1.61e-05	0.000132	CcSEcCtD
Capecitabine—Abdominal pain upper—Doxorubicin—kidney cancer	1.61e-05	0.000132	CcSEcCtD
Capecitabine—Nervous system disorder—Paclitaxel—kidney cancer	1.6e-05	0.000132	CcSEcCtD
Capecitabine—Hypokalaemia—Doxorubicin—kidney cancer	1.6e-05	0.000132	CcSEcCtD
Capecitabine—Thrombocytopenia—Paclitaxel—kidney cancer	1.6e-05	0.000132	CcSEcCtD
Capecitabine—Tachycardia—Paclitaxel—kidney cancer	1.6e-05	0.000132	CcSEcCtD
Capecitabine—Rash—Sorafenib—kidney cancer	1.59e-05	0.000131	CcSEcCtD
Capecitabine—Dermatitis—Sorafenib—kidney cancer	1.59e-05	0.000131	CcSEcCtD
Capecitabine—Breast disorder—Doxorubicin—kidney cancer	1.59e-05	0.000131	CcSEcCtD
Capecitabine—Skin disorder—Paclitaxel—kidney cancer	1.59e-05	0.000131	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.58e-05	0.000131	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	1.58e-05	0.000131	CcSEcCtD
Capecitabine—Headache—Sorafenib—kidney cancer	1.58e-05	0.000131	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	1.58e-05	0.00052	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Paclitaxel—kidney cancer	1.58e-05	0.00013	CcSEcCtD
Capecitabine—Diarrhoea—Dactinomycin—kidney cancer	1.58e-05	0.00013	CcSEcCtD
Capecitabine—Nasopharyngitis—Doxorubicin—kidney cancer	1.57e-05	0.00013	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	1.56e-05	0.000513	CbGpPWpGaD
Capecitabine—Anorexia—Paclitaxel—kidney cancer	1.56e-05	0.000128	CcSEcCtD
Capecitabine—Gastritis—Doxorubicin—kidney cancer	1.56e-05	0.000128	CcSEcCtD
Capecitabine—Muscular weakness—Doxorubicin—kidney cancer	1.55e-05	0.000128	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	1.55e-05	0.000128	CcSEcCtD
Capecitabine—Vomiting—Sunitinib—kidney cancer	1.55e-05	0.000128	CcSEcCtD
Capecitabine—Body temperature increased—Gemcitabine—kidney cancer	1.54e-05	0.000127	CcSEcCtD
Capecitabine—Rash—Sunitinib—kidney cancer	1.53e-05	0.000126	CcSEcCtD
Capecitabine—Dermatitis—Sunitinib—kidney cancer	1.53e-05	0.000126	CcSEcCtD
Capecitabine—Abdominal distension—Doxorubicin—kidney cancer	1.53e-05	0.000126	CcSEcCtD
Capecitabine—Hypotension—Paclitaxel—kidney cancer	1.53e-05	0.000126	CcSEcCtD
Capecitabine—Headache—Sunitinib—kidney cancer	1.52e-05	0.000126	CcSEcCtD
Capecitabine—Dysphagia—Doxorubicin—kidney cancer	1.52e-05	0.000125	CcSEcCtD
Capecitabine—Influenza—Doxorubicin—kidney cancer	1.52e-05	0.000125	CcSEcCtD
Capecitabine—Asthma—Doxorubicin—kidney cancer	1.52e-05	0.000125	CcSEcCtD
Capecitabine—Hypersensitivity—Vincristine—kidney cancer	1.52e-05	0.000125	CcSEcCtD
Capecitabine—Nausea—Sorafenib—kidney cancer	1.5e-05	0.000124	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	1.5e-05	0.000493	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.49e-05	0.000123	CcSEcCtD
Capecitabine—Angina pectoris—Doxorubicin—kidney cancer	1.48e-05	0.000122	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	1.48e-05	0.000486	CbGpPWpGaD
Capecitabine—Insomnia—Paclitaxel—kidney cancer	1.48e-05	0.000122	CcSEcCtD
Capecitabine—Asthenia—Vincristine—kidney cancer	1.48e-05	0.000122	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTT1—kidney cancer	1.47e-05	0.000485	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ACHE—kidney cancer	1.47e-05	0.000485	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.47e-05	0.000484	CbGpPWpGaD
Capecitabine—Paraesthesia—Paclitaxel—kidney cancer	1.47e-05	0.000121	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—kidney cancer	1.47e-05	0.000121	CcSEcCtD
Capecitabine—Bronchitis—Doxorubicin—kidney cancer	1.46e-05	0.000121	CcSEcCtD
Capecitabine—Dyspnoea—Paclitaxel—kidney cancer	1.46e-05	0.00012	CcSEcCtD
Capecitabine—Rash—Dactinomycin—kidney cancer	1.45e-05	0.00012	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTGS2—kidney cancer	1.45e-05	0.000477	CbGpPWpGaD
Capecitabine—Nausea—Sunitinib—kidney cancer	1.45e-05	0.000119	CcSEcCtD
Capecitabine—Pancytopenia—Doxorubicin—kidney cancer	1.44e-05	0.000119	CcSEcCtD
Capecitabine—Dyspepsia—Paclitaxel—kidney cancer	1.44e-05	0.000119	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—kidney cancer	1.42e-05	0.000117	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—kidney cancer	1.42e-05	0.000117	CcSEcCtD
Capecitabine—Decreased appetite—Paclitaxel—kidney cancer	1.42e-05	0.000117	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.41e-05	0.000117	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.41e-05	0.000116	CcSEcCtD
Capecitabine—Fatigue—Paclitaxel—kidney cancer	1.41e-05	0.000116	CcSEcCtD
Capecitabine—Diarrhoea—Vincristine—kidney cancer	1.41e-05	0.000116	CcSEcCtD
Capecitabine—Asthenia—Gemcitabine—kidney cancer	1.4e-05	0.000115	CcSEcCtD
Capecitabine—Pain—Paclitaxel—kidney cancer	1.4e-05	0.000115	CcSEcCtD
Capecitabine—Constipation—Paclitaxel—kidney cancer	1.4e-05	0.000115	CcSEcCtD
Capecitabine—TYMS—Metabolism—SCARB1—kidney cancer	1.39e-05	0.000459	CbGpPWpGaD
Capecitabine—Photosensitivity reaction—Doxorubicin—kidney cancer	1.39e-05	0.000114	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—kidney cancer	1.38e-05	0.000114	CcSEcCtD
Capecitabine—Pruritus—Gemcitabine—kidney cancer	1.38e-05	0.000114	CcSEcCtD
Capecitabine—TYMS—Metabolism—PTGS1—kidney cancer	1.38e-05	0.000454	CbGpPWpGaD
Capecitabine—Weight decreased—Doxorubicin—kidney cancer	1.38e-05	0.000113	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—kidney cancer	1.37e-05	0.000113	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—kidney cancer	1.37e-05	0.000113	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—kidney cancer	1.36e-05	0.000112	CcSEcCtD
Capecitabine—Dizziness—Vincristine—kidney cancer	1.36e-05	0.000112	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—kidney cancer	1.36e-05	0.000112	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—kidney cancer	1.36e-05	0.000112	CcSEcCtD
Capecitabine—TYMS—Metabolism—PSMD7—kidney cancer	1.35e-05	0.000445	CbGpPWpGaD
Capecitabine—Feeling abnormal—Paclitaxel—kidney cancer	1.35e-05	0.000111	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.34e-05	0.000111	CcSEcCtD
Capecitabine—Gastrointestinal pain—Paclitaxel—kidney cancer	1.34e-05	0.00011	CcSEcCtD
Capecitabine—Diarrhoea—Gemcitabine—kidney cancer	1.34e-05	0.00011	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—kidney cancer	1.33e-05	0.00011	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.33e-05	0.00011	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—kidney cancer	1.32e-05	0.000109	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—kidney cancer	1.32e-05	0.000109	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ACY1—kidney cancer	1.32e-05	0.000434	CbGpPWpGaD
Capecitabine—Conjunctivitis—Doxorubicin—kidney cancer	1.32e-05	0.000109	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—kidney cancer	1.32e-05	0.000109	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2A—kidney cancer	1.32e-05	0.000433	CbGpPWpGaD
Capecitabine—Vomiting—Vincristine—kidney cancer	1.31e-05	0.000108	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.3e-05	0.000429	CbGpPWpGaD
Capecitabine—Urticaria—Paclitaxel—kidney cancer	1.3e-05	0.000107	CcSEcCtD
Capecitabine—Rash—Vincristine—kidney cancer	1.3e-05	0.000107	CcSEcCtD
Capecitabine—Dermatitis—Vincristine—kidney cancer	1.3e-05	0.000107	CcSEcCtD
Capecitabine—TYMP—Metabolism—POMC—kidney cancer	1.3e-05	0.000426	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—kidney cancer	1.29e-05	0.000426	CbGpPWpGaD
Capecitabine—Haematuria—Doxorubicin—kidney cancer	1.29e-05	0.000107	CcSEcCtD
Capecitabine—Body temperature increased—Paclitaxel—kidney cancer	1.29e-05	0.000107	CcSEcCtD
Capecitabine—Abdominal pain—Paclitaxel—kidney cancer	1.29e-05	0.000107	CcSEcCtD
Capecitabine—Headache—Vincristine—kidney cancer	1.29e-05	0.000106	CcSEcCtD
Capecitabine—TYMS—Metabolism—BCHE—kidney cancer	1.28e-05	0.000422	CbGpPWpGaD
Capecitabine—Hepatobiliary disease—Doxorubicin—kidney cancer	1.28e-05	0.000106	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—kidney cancer	1.28e-05	0.000105	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC5A5—kidney cancer	1.27e-05	0.000417	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—kidney cancer	1.27e-05	0.000416	CbGpPWpGaD
Capecitabine—Agranulocytosis—Doxorubicin—kidney cancer	1.27e-05	0.000104	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	1.24e-05	0.000409	CbGpPWpGaD
Capecitabine—Vomiting—Gemcitabine—kidney cancer	1.24e-05	0.000102	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—kidney cancer	1.24e-05	0.000102	CcSEcCtD
Capecitabine—Rash—Gemcitabine—kidney cancer	1.23e-05	0.000101	CcSEcCtD
Capecitabine—Dermatitis—Gemcitabine—kidney cancer	1.23e-05	0.000101	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC2A1—kidney cancer	1.22e-05	0.000403	CbGpPWpGaD
Capecitabine—Haemoglobin—Doxorubicin—kidney cancer	1.22e-05	0.000101	CcSEcCtD
Capecitabine—Headache—Gemcitabine—kidney cancer	1.22e-05	0.000101	CcSEcCtD
Capecitabine—Nausea—Vincristine—kidney cancer	1.22e-05	0.000101	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—kidney cancer	1.22e-05	0.000101	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—kidney cancer	1.22e-05	0.0001	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—kidney cancer	1.22e-05	0.0001	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—kidney cancer	1.21e-05	9.98e-05	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—kidney cancer	1.21e-05	9.96e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Paclitaxel—kidney cancer	1.2e-05	9.93e-05	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—kidney cancer	1.2e-05	9.91e-05	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—kidney cancer	1.2e-05	9.88e-05	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—kidney cancer	1.2e-05	9.86e-05	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—kidney cancer	1.19e-05	9.84e-05	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—kidney cancer	1.17e-05	9.67e-05	CcSEcCtD
Capecitabine—Asthenia—Paclitaxel—kidney cancer	1.17e-05	9.67e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN1B—kidney cancer	1.17e-05	0.000384	CbGpPWpGaD
Capecitabine—Nausea—Gemcitabine—kidney cancer	1.16e-05	9.56e-05	CcSEcCtD
Capecitabine—Pruritus—Paclitaxel—kidney cancer	1.16e-05	9.53e-05	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—kidney cancer	1.15e-05	9.49e-05	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—kidney cancer	1.14e-05	9.38e-05	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—kidney cancer	1.14e-05	9.36e-05	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—kidney cancer	1.13e-05	9.31e-05	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—kidney cancer	1.13e-05	9.31e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PTEN—kidney cancer	1.13e-05	0.000371	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.12e-05	0.00037	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PDHB—kidney cancer	1.12e-05	0.000369	CbGpPWpGaD
Capecitabine—Diarrhoea—Paclitaxel—kidney cancer	1.12e-05	9.22e-05	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—POMC—kidney cancer	1.12e-05	0.000368	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—kidney cancer	1.11e-05	0.000366	CbGpPWpGaD
Capecitabine—Angiopathy—Doxorubicin—kidney cancer	1.1e-05	9.1e-05	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—kidney cancer	1.1e-05	9.06e-05	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—kidney cancer	1.1e-05	9.04e-05	CcSEcCtD
Capecitabine—Chills—Doxorubicin—kidney cancer	1.09e-05	9e-05	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—kidney cancer	1.09e-05	8.96e-05	CcSEcCtD
Capecitabine—Dizziness—Paclitaxel—kidney cancer	1.08e-05	8.91e-05	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—kidney cancer	1.08e-05	8.87e-05	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—kidney cancer	1.07e-05	8.79e-05	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—kidney cancer	1.06e-05	8.73e-05	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—kidney cancer	1.06e-05	8.73e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CCBL1—kidney cancer	1.05e-05	0.000347	CbGpPWpGaD
Capecitabine—Flatulence—Doxorubicin—kidney cancer	1.04e-05	8.61e-05	CcSEcCtD
Capecitabine—Vomiting—Paclitaxel—kidney cancer	1.04e-05	8.57e-05	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—kidney cancer	1.04e-05	8.55e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTGS2—kidney cancer	1.03e-05	0.00034	CbGpPWpGaD
Capecitabine—Rash—Paclitaxel—kidney cancer	1.03e-05	8.5e-05	CcSEcCtD
Capecitabine—Dermatitis—Paclitaxel—kidney cancer	1.03e-05	8.49e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.03e-05	0.000338	CbGpPWpGaD
Capecitabine—Back pain—Doxorubicin—kidney cancer	1.03e-05	8.45e-05	CcSEcCtD
Capecitabine—Headache—Paclitaxel—kidney cancer	1.02e-05	8.44e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000336	CbGpPWpGaD
Capecitabine—Muscle spasms—Doxorubicin—kidney cancer	1.02e-05	8.4e-05	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—kidney cancer	9.99e-06	8.23e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	9.98e-06	0.000328	CbGpPWpGaD
Capecitabine—Ill-defined disorder—Doxorubicin—kidney cancer	9.83e-06	8.1e-05	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—kidney cancer	9.8e-06	8.07e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	9.77e-06	0.000321	CbGpPWpGaD
Capecitabine—Nausea—Paclitaxel—kidney cancer	9.71e-06	8e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ABCB1—kidney cancer	9.67e-06	0.000318	CbGpPWpGaD
Capecitabine—Malaise—Doxorubicin—kidney cancer	9.56e-06	7.88e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	9.54e-06	0.000314	CbGpPWpGaD
Capecitabine—Vertigo—Doxorubicin—kidney cancer	9.52e-06	7.85e-05	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—kidney cancer	9.5e-06	7.83e-05	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—kidney cancer	9.49e-06	7.82e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTM1—kidney cancer	9.39e-06	0.000309	CbGpPWpGaD
Capecitabine—Palpitations—Doxorubicin—kidney cancer	9.37e-06	7.72e-05	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—kidney cancer	9.32e-06	7.68e-05	CcSEcCtD
Capecitabine—Cough—Doxorubicin—kidney cancer	9.25e-06	7.62e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MAPK3—kidney cancer	9.18e-06	0.000302	CbGpPWpGaD
Capecitabine—Hypertension—Doxorubicin—kidney cancer	9.15e-06	7.54e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—GLIPR1—kidney cancer	9.14e-06	0.000301	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPAT—kidney cancer	9.14e-06	0.000301	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.03e-06	0.000297	CbGpPWpGaD
Capecitabine—Myalgia—Doxorubicin—kidney cancer	9.02e-06	7.44e-05	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—kidney cancer	9.02e-06	7.44e-05	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—kidney cancer	9.02e-06	7.44e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTEN—kidney cancer	9.02e-06	0.000297	CbGpPWpGaD
Capecitabine—Anxiety—Doxorubicin—kidney cancer	8.99e-06	7.41e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.96e-06	7.39e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.94e-06	0.000294	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—kidney cancer	8.93e-06	0.000294	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—kidney cancer	8.93e-06	0.000294	CbGpPWpGaD
Capecitabine—Discomfort—Doxorubicin—kidney cancer	8.91e-06	7.35e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP1A1—kidney cancer	8.9e-06	0.000293	CbGpPWpGaD
Capecitabine—Dry mouth—Doxorubicin—kidney cancer	8.82e-06	7.27e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MAPK1—kidney cancer	8.73e-06	0.000287	CbGpPWpGaD
Capecitabine—Confusional state—Doxorubicin—kidney cancer	8.72e-06	7.19e-05	CcSEcCtD
Capecitabine—Oedema—Doxorubicin—kidney cancer	8.65e-06	7.13e-05	CcSEcCtD
Capecitabine—Infection—Doxorubicin—kidney cancer	8.59e-06	7.08e-05	CcSEcCtD
Capecitabine—Shock—Doxorubicin—kidney cancer	8.51e-06	7.01e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—FH—kidney cancer	8.5e-06	0.00028	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APRT—kidney cancer	8.5e-06	0.00028	CbGpPWpGaD
Capecitabine—Nervous system disorder—Doxorubicin—kidney cancer	8.48e-06	6.99e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—kidney cancer	8.47e-06	6.98e-05	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—kidney cancer	8.44e-06	6.96e-05	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—kidney cancer	8.4e-06	6.92e-05	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—kidney cancer	8.36e-06	6.89e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.31e-06	0.000273	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—kidney cancer	8.25e-06	6.8e-05	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—kidney cancer	8.08e-06	6.66e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—GPC3—kidney cancer	7.99e-06	0.000263	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—kidney cancer	7.96e-06	0.000262	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.88e-06	6.49e-05	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—kidney cancer	7.82e-06	6.45e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CA2—kidney cancer	7.77e-06	0.000256	CbGpPWpGaD
Capecitabine—Paraesthesia—Doxorubicin—kidney cancer	7.77e-06	6.4e-05	CcSEcCtD
Capecitabine—Dyspnoea—Doxorubicin—kidney cancer	7.71e-06	6.36e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—kidney cancer	7.61e-06	6.28e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ALAD—kidney cancer	7.58e-06	0.000249	CbGpPWpGaD
Capecitabine—Decreased appetite—Doxorubicin—kidney cancer	7.52e-06	6.2e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.47e-06	6.15e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—kidney cancer	7.46e-06	6.15e-05	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—kidney cancer	7.4e-06	6.1e-05	CcSEcCtD
Capecitabine—Pain—Doxorubicin—kidney cancer	7.4e-06	6.1e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	7.39e-06	0.000243	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—kidney cancer	7.33e-06	0.000241	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	7.23e-06	0.000238	CbGpPWpGaD
Capecitabine—Feeling abnormal—Doxorubicin—kidney cancer	7.13e-06	5.87e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.07e-06	5.83e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—PGK1—kidney cancer	6.93e-06	0.000228	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A3—kidney cancer	6.93e-06	0.000228	CbGpPWpGaD
Capecitabine—Urticaria—Doxorubicin—kidney cancer	6.87e-06	5.66e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—kidney cancer	6.84e-06	5.64e-05	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—kidney cancer	6.84e-06	5.64e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—LDHB—kidney cancer	6.8e-06	0.000223	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—POMC—kidney cancer	6.63e-06	0.000218	CbGpPWpGaD
Capecitabine—Hypersensitivity—Doxorubicin—kidney cancer	6.37e-06	5.25e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CA—kidney cancer	6.36e-06	0.000209	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—kidney cancer	6.21e-06	5.11e-05	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—kidney cancer	6.12e-06	5.04e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—kidney cancer	5.92e-06	4.88e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CA9—kidney cancer	5.89e-06	0.000194	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.76e-06	0.000189	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—kidney cancer	5.72e-06	4.71e-05	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—kidney cancer	5.5e-06	4.53e-05	CcSEcCtD
Capecitabine—Rash—Doxorubicin—kidney cancer	5.45e-06	4.49e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—kidney cancer	5.45e-06	4.49e-05	CcSEcCtD
Capecitabine—Headache—Doxorubicin—kidney cancer	5.42e-06	4.47e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PTGS2—kidney cancer	5.29e-06	0.000174	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—kidney cancer	5.14e-06	4.23e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CRABP1—kidney cancer	5.01e-06	0.000165	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ITPR2—kidney cancer	4.66e-06	0.000153	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—kidney cancer	4.61e-06	0.000152	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.29e-06	0.000141	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACHE—kidney cancer	4.25e-06	0.00014	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—kidney cancer	4.25e-06	0.00014	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SCARB1—kidney cancer	4.02e-06	0.000132	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS1—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMD7—kidney cancer	3.9e-06	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCHE—kidney cancer	3.7e-06	0.000122	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.65e-06	0.00012	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.53e-06	0.000116	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.42e-06	0.000113	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—kidney cancer	3.26e-06	0.000107	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.99e-06	9.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—kidney cancer	2.94e-06	9.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.79e-06	9.16e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—kidney cancer	2.71e-06	8.9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.56e-06	8.43e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.11e-06	6.93e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—kidney cancer	1.91e-06	6.29e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.53e-06	5.02e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—kidney cancer	1.33e-06	4.37e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—kidney cancer	9.38e-07	3.09e-05	CbGpPWpGaD
